| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Bertolini Robert J is a Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 142 sells.
Estimated insider holdings value: $5.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 20, 2020 | CRL Charles River Laboratories International, Inc. | Director | Sale+OE | 3,530 | $174.58 | $616,262.81 | -10.8% | |
| Feb 13, 2020 | CRL Charles River Laboratories International, Inc. | Director | Sale+OE | 7,170 | $170.41 | $1,221,818.91 | -20.5% | |
| Jul 31, 2019 | BMY Bristol Myers Squibb Co | Director | Buy | 11,000 | $44.72 | $491,920.00 | +2,771% | |
| Dec 4, 2018 | CRL Charles River Laboratories International, Inc. | Director | Sale+OE | 3,440 | $133.77 | $460,154.47 | -0.4% | |
| Dec 4, 2018 | CRL Charles River Laboratories International, Inc. | Director | Sell | 1,100 | $134.71 | $148,179.00 | -0.4% | |
| Jan 2, 2018 | CRL Charles River Laboratories International, Inc. | Director | Sell | 4,988 | $110.16 | $549,480.09 | -0.8% | |
| Jan 2, 2018 | CRL Charles River Laboratories International, Inc. | Director | Sale+OE | 3,809 | $109.56 | $417,331.50 | -0.5% | |
| Mar 1, 2017 | CRL Charles River Laboratories International, Inc. | Director | Sale+OE | 5,255 | $87.53 | $459,988.10 | -0.6% | |
| Mar 1, 2017 | CRL Charles River Laboratories International, Inc. | Director | Sell | 6,735 | $88.00 | $592,701.71 | -1.3% |